pharmaceutical-investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical-investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
pharmaceutical-investing Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical-investing Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline
pharmaceutical-investing Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines
pharmaceutical-investing Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline
Benz Announces that Icon Delivers Shallow High-Grade Discovery as Large-Scale System Continues to Grow
Benz Announces that Icon Delivers Shallow High-Grade Discovery as Large-Scale System Continues to Grow
